ALTOBELLI, DEBORA
ALTOBELLI, DEBORA
Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH)
2023 Gidari, Anna; Benedetti, Sara; Tordi, Sara; Zoffoli, Anastasia; Altobelli, Debora; Schiaroli, Elisabetta; De Socio, Giuseppe Vittorio; Francisci, Daniela
Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy in a Real-Life Cohort of Virogically Suppressed People Living with HIV
2023 De Socio, Giuseppe Vittorio; Tordi, Sara; Altobelli, Debora; Gidari, Anna; Zoffoli, Anastasia; Francisci, Daniela
Effectiveness, safety and tolerability of dolutegravir/lamivudine versus tenofovir alafenamide/emtricitabine/bictegravir in a real-life cohort of HIV-1 virologically suppressed treatment experienced people living with HIV
2023 Tordi, S; De Socio, G; Altobelli, D; Gidari, A; Zoffoli, A; Francisci, D
Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people living with HIVfrom the STOPSHIV cohort
2025 De Socio, G.; Ricci, E.; Piconi, S.; Squillace, N.; Maggi, P.; Orofino, G.; Altobelli, D.; Santoro, C.; Guastavigna, M.; Menzaghi, B.; Salomoni, E.; Di Biagio, A.; Dell'Omo, M.; Francisci, D.; Bonfanti, P.
Real-life monocentric Biktarvy cohort from Perugia
2022 Benedetti, S; Altobelli, D; De Socio, G; Lanzi, A; Gamboni, G; Francisci, D
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH) | 2023 | Gidari, Anna; Benedetti, Sara; Tordi, Sara; Zoffoli, Anastasia; Altobelli, Debora; Schiaroli, Elisabetta; De Socio, Giuseppe Vittorio; Francisci, Daniela | |
| Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy in a Real-Life Cohort of Virogically Suppressed People Living with HIV | 2023 | De Socio, Giuseppe Vittorio; Tordi, Sara; Altobelli, Debora; Gidari, Anna; Zoffoli, Anastasia; Francisci, Daniela | |
| Effectiveness, safety and tolerability of dolutegravir/lamivudine versus tenofovir alafenamide/emtricitabine/bictegravir in a real-life cohort of HIV-1 virologically suppressed treatment experienced people living with HIV | 2023 | Tordi, S; De Socio, G; Altobelli, D; Gidari, A; Zoffoli, A; Francisci, D | |
| Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people living with HIVfrom the STOPSHIV cohort | 2025 | De Socio, G.; Ricci, E.; Piconi, S.; Squillace, N.; Maggi, P.; Orofino, G.; Altobelli, D.; Santoro, C.; Guastavigna, M.; Menzaghi, B.; Salomoni, E.; Di Biagio, A.; Dell'Omo, M.; Francisci, D.; Bonfanti, P. | |
| Real-life monocentric Biktarvy cohort from Perugia | 2022 | Benedetti, S; Altobelli, D; De Socio, G; Lanzi, A; Gamboni, G; Francisci, D |